期刊文献+

耐碳青霉烯类肠杆菌科细菌耐药机制和危险因素研究进展 被引量:12

Resistance mechanism and molecular epidemiology progress of carbapenem-resistant enterobacteriaceae
下载PDF
导出
摘要 随着抗生素的不合理使用,耐碳青霉烯类肠杆菌科细菌已成为公众健康的一大威胁,因其预后差,传播广泛而引起了全世界范围的关注和研究,且已经成为导致患者死亡的重要因素之一。我国的耐药菌感染率也在不断升高,以产碳青霉烯酶的耐碳青霉烯类肠杆菌科细菌(CRE)为主。在评估CRE感染的研究中,人们发现传播过程和预防感染同样重要。该文将从CRE的耐药机制,分子流行病学和危险因素等方面的研究进展进行阐述。 With the inappropriate use of antibiotics,carbapenem-resistant Enterobacteriaceae bacteria (CRE) has become a serious public health threat.Due to its worldwide prevalence and poor prognosis,infection by CRE is one of the important causes of death,which has attracted worldwide attention and research.In our country,the infection rate of drug-resistant bacteria is also increasing,mainly based on CRE producing carbapenemase.In the research of assessing CRE infection,people found that the process of transmission is as important as the prevention strategies.In this review, we will expound the research progress of the resistance mechanism of CRE,molecular epidemiology and risk factors.
作者 陶慧婷 杨旭 Tao Huiting;Yang Xu(Clinical laboratory Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China)
出处 《中国临床保健杂志》 CAS 2018年第6期849-853,共5页 Chinese Journal of Clinical Healthcare
关键词 抗药性 细菌 处方不当 肠杆菌科 分子流行病学 危险因素 Drug resistance,bacterial Inappropriate prescribing Enterobacteriaceae Molecular epidemiology Risk factors
  • 相关文献

参考文献4

二级参考文献18

  • 1Yigit H,Queenan AM,Anderson GJ,Domenech-Sanchez A,Biddle JW,Steward CD,et al.Novel carbapenem-hydrolyzing β-1actamase,KPC-1,from a carbapenem-resistant strain of Klebsiella pneumoniae.Antimicrob Agents Chemother 2001;45:1151-1161. 被引量:1
  • 2Yigit H,Queenan AM,Rasheed JK,Biddle JW,Domenech-Sanchez A,Alberti S,et al.Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenemhydrolyzing β-lactamase KPC-2.Antimicrob Agents Chemother 2003; 47:3881-3889. 被引量:1
  • 3Navon-Venezia S,Chmelnitsky I,Leavitt A,Schwaber MJ,Schwartz D,Carmeli Y.Plasmid-mediated imipenemhydrolyzing enzyme KPC-2 among multiple carbapenemresistant Escherichia coli clones in Israel.Antimicrob Agents Chemother 2006; 50:3098-3101. 被引量:1
  • 4Deshpande LM,Rhomberg PR,Sader HS,Jones RN.Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers:report from the MYSTIC program (1999-2005).Diagn Microbiol Infect Dis 2006; 56:367-372. 被引量:1
  • 5Villegas MV,Lolans K,Correa A,Kattan JN,Lopez JA,Quinn JP,et al.First identification of Pseudomonas aeruginosa isolates producing a KPC type carbapenemhydrolyzing β-lactamase.Antimicrob Agents Chemother 2007;51:1553-1555. 被引量:1
  • 6Miriagou V,Tzouvelekis LS,Rossiter S,Tzelepi E,Angulo FJ,Whichard JM.Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.Antimicrob Agents Chemother 2003; 47:1297-1300. 被引量:1
  • 7Tibbetts R,Frye JG,Marschall J,Warren D,Dunne W.Detecton of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P.mirabilis.J Clin Microbiol 2008; 46:3080-3083. 被引量:1
  • 8Neuwirth C,Siebor E,Duez JM,Pechinot A,Kazmierczak A.Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.J Antimicrob Chemother 1995; 36:335-342. 被引量:1
  • 9Villar HE,Danel F,Livermore DM.Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.J Antimicrob Chemother 1997; 40:365-370. 被引量:1
  • 10Clinical and Laboratory Standards Institute.2006.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard.CLSI document M7-A6.Clinical and Laboratory Standards Institute,Wayne,PA. 被引量:1

共引文献781

同被引文献98

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部